Cannara expands financing to an $80 million syndicated credit facility
Cannara Biotech expanded financing to an $80 million syndicated credit facility with BMO and TD Bank. The structure includes an expanded $40 million revolving credit facility, reduced borrowing costs, and extended maturity.
The new financing structure provides greater financial flexibility through an expanded $40 million revolving credit facility, reduced borrowing costs and an extended maturity to December 31, 2029MONTREAL, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, the “Company”, “us” or “we…